A
ALKS
Alkermes Plc
47.72
+0.52+1.10%After Hours: 47.70 -0.02 -0.04%19:30 09/02 EDT
OPEN/PREV CLOSE47.70/47.20
TODAY RANGE46.68-48.74
VOL1.57M
MARKET CAP8.01B
52 WEEK RANGE25.17-55.67
AVG VOL (3M)1.94M
% TURNOVER0.85%
TURNOVER--
P/E (TTM)123.98
% RANGE4.27%
EPS(TTM)0.3849
P/E(FORWARD)-93.5374
P/B4.421
BVPS10.79
DIVIDEND--
P/S5.35
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.86B
SHARES OUTSTANDING167.76M
NEXT EARNINGS10/26-10/30
FREE FLOAT164.70M
LOT SIZE1
EX-DATE11/16/2023
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)
TipRanks·6d ago
Trump Trade: U.S. considering new semiconductor tariffs
Simply Wall St·6d ago
Did Positive Vibrance-1 Data and Brilliance Phase 3 Launch Just Shift Alkermes' (ALKS) Investment Narrative?
TipRanks·08/24 22:35
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
NASDAQ·08/21 16:40
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
NASDAQ·08/21 14:48
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Simply Wall St·08/20 16:27
Alkermes (ALKS) Cuts Loan Costs, Is The 10% Undervalued View Convincing?
NASDAQ·08/12 15:22
ALKS Stock Rises 27% in 3 Months: Here's What You Should Know
TipRanks·08/12 13:49
Alkermes Amends Credit Agreement to Lower Borrowing Costs
Simply Wall St·08/09 09:33
Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative?
Simply Wall St·08/08 04:35
Alkermes (ALKS) Faces A Fresh Valuation Test Following Earnings Guidance And Shelf Filing
The Wall Street Journal·08/07 17:11
Correction to Sleep Drug Article on Aug. 6